Fsd Pharma Inc Cl B (HUGE) |
|
2.1578 -0.052 (-2.36%)
|
02-25 11:24 |
|
Open: |
2.24 |
Pre. Close: |
2.21 |
|
High:
|
2.28 |
Low:
|
2.08 |
|
Volume:
|
622,095 |
Market Cap:
|
41M |
|
|
|
|
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.283 - 2.296 |
2.296 - 2.308 |
|
Low:
|
2.068 - 2.084 |
2.084 - 2.098 |
|
Close:
|
2.186 - 2.21 |
2.21 - 2.232 |
|
Technical analysis |
as of: 2021-02-25 11:12:41 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.00 One year: 5.19 |
| Support: |
Support1: 1.78 Support2: 1.48 |
| Resistance: |
Resistance1: 3.42 Resistance2: 4.44 |
| Pivot: |
2.56  |
| Moving Average: |
MA(5): 2.22 MA(20): 2.43 
MA(100): 1.97 MA(250): 2.84 |
| MACD: |
MACD(12,26): 0.04 Signal(9): 0.13 |
| Stochastic oscillator: |
%K(14,3): 5.18 %D(3): 8.82 |
| RSI: |
RSI(14): 45.41 |
| 52-week: |
High: 14.00 Low: 1.28 Change(%): -49.2 |
| Average Vol(K): |
3-Month: 271838 10-Days: 361001 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.HUGE has closed above bottom band by 25.8%. Bollinger Bands are 135.8% wider than normal. The large width of the bands suggest high volatility as compared to HUGE's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 11 Feb 2021
FSD Pharma Announces US$20M At-The-Market Offering - Yahoo Finance
Wed, 10 Feb 2021
92 Biggest Movers From Yesterday - Benzinga
Wed, 27 Jan 2021
FSD Pharma Fires President, Certain Shareholders Look To Takeover Company - The Deep Dive
Tue, 26 Jan 2021
FSD Provides Corporate Update - Business Wire
Fri, 22 Jan 2021
FSD Pharma Sets Date for Annual Meeting - Business Wire
Thu, 12 Nov 2020
FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update - Business Wire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
19 |
| Shares Float (M) |
16 |
|
% Held by Insiders
|
12.70 |
|
% Held by Institutions
|
0.73 |
|
Shares Short (K)
|
92 |
|
Shares Short P. Month (K)
|
74 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-46.2 |
|
Return on Equity (ttm)
|
-105.0 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
-0.174 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
